Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.
about
Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccinesUse of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoproteinProtection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.Polymeric Materials for Gene Delivery and DNA VaccinationIntranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challengeA trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers.DNA vaccines: ready for prime time?The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine.Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.Polymers for gene delivery across length scales.Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques.Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron ANanoparticles and microparticles as vaccine-delivery systems.Heterologous prime-boost vaccination.Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity.Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.Future Approaches to DNA Vaccination Against Hemorrhagic Fever Viruses.The potential of the CMB305 vaccine regimen to target NY-ESO-1 and improve outcomes for synovial sarcoma and myxoid/round cell liposarcoma patients.3rd annual DNA vaccines forum.
P2860
Q27333734-DA2F7084-1FF3-4940-9198-7490743F133EQ28730561-E13328D6-A835-48F1-9BB6-65A1B6C677C7Q33303670-897A594D-F17D-4055-BB93-577EB0D5885CQ33565296-D52A5592-678E-483B-A3A0-9EED4E2EC0A4Q34081625-37D5CE62-C506-46D0-B787-CAC56DE16009Q34743297-90613AC0-EA69-438E-AAB1-DA0AFA45D1C9Q34824179-B0ED1D5B-E736-4F73-B829-BCAA0C91D6AFQ35271066-1E7BE040-FC3C-4720-A2C1-7A9E90273CFBQ36098933-8341D07E-7E86-4FFF-8FE5-AF37FB363E3FQ36494142-CAADAA71-8EC0-4590-A9CF-AC12E134D430Q36539048-9B569B5F-C286-4FEE-88B9-02DF567E57B0Q36540068-8816AA65-B8BE-467F-AF5C-4DB8F0D04D48Q36968297-1A3D9C1D-D53B-4370-A7E0-E78A6430F80AQ37509586-27D94C6C-55EF-4803-93AE-B1DA0739B45FQ37812128-EE990671-3778-46EC-9142-11714F51834CQ38152851-08F73A3C-020C-4C1F-82E4-A87E1C1CD0E5Q38730774-BC26A771-FDDA-4193-8711-10FB73BB6765Q39601936-455364D2-3D89-4C4B-A0A4-DE894593CB35Q41922339-C275239C-D3E5-490E-8B2B-032E583CDBE2Q47244891-C2AD2718-9A90-499E-BD04-E39F9C36CA66Q51104214-E4978A14-56D6-4454-9482-60321D5C25A7
P2860
Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Enhanced potency of plasmid DN ...... men with recombinant proteins.
@en
Enhanced potency of plasmid DN ...... men with recombinant proteins.
@nl
type
label
Enhanced potency of plasmid DN ...... men with recombinant proteins.
@en
Enhanced potency of plasmid DN ...... men with recombinant proteins.
@nl
prefLabel
Enhanced potency of plasmid DN ...... men with recombinant proteins.
@en
Enhanced potency of plasmid DN ...... men with recombinant proteins.
@nl
P2093
P2860
P1433
P1476
Enhanced potency of plasmid DN ...... men with recombinant proteins.
@en
P2093
Barbara Doe
David A Driver
Derek T O'Hagan
Gillis R Otten
Indresh Srivastava
Jan zur Megede
Jeffrey B Ulmer
Jina Kazzaz
John Donnelly
P2860
P304
P356
10.1128/JVI.79.13.8189-8200.2005
P407
P577
2005-07-01T00:00:00Z